Home / Import refusals / 510-2147301-5/2/1

510-2147301-5/2/1

Takeda Pharmaceutical Company Limited — FEI 3002808311

Recent inspections

  • 1238763 (NAI Fri Apr 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1100693 (VAI Fri Aug 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1028828 (NAI Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 943082 (VAI Fri Sep 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 853928 (VAI Fri Sep 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • NUV-3881703-0/100002/1 (Tue Feb 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • NUV-3881703-0/80002/1 (Tue Feb 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-7622704-2/12/1 (Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-4270100-7/11/1 (Fri Jun 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-3879562-5/191/1 (Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

Refusal Details

Date
April 18, 2016
Country
Japan
Product Category
Drugs and Biologics
Product Code
62CCA99 ANTI-HYPERTENSIVE N.E.C.
Charges
118,16,3280,75